Vita, Alessia
 Distribuzione geografica
Continente #
EU - Europa 42
AS - Asia 34
NA - Nord America 34
SA - Sud America 13
AF - Africa 2
Totale 125
Nazione #
US - Stati Uniti d'America 32
CN - Cina 14
IT - Italia 13
SG - Singapore 12
BR - Brasile 11
DE - Germania 6
FR - Francia 6
GB - Regno Unito 4
KR - Corea 4
AT - Austria 3
FI - Finlandia 3
SE - Svezia 3
RU - Federazione Russa 2
CI - Costa d'Avorio 1
EG - Egitto 1
HK - Hong Kong 1
ID - Indonesia 1
IE - Irlanda 1
MX - Messico 1
NL - Olanda 1
SV - El Salvador 1
TR - Turchia 1
TW - Taiwan 1
UY - Uruguay 1
VE - Venezuela 1
Totale 125
Città #
Milan 8
Singapore 6
Ashburn 5
The Dalles 5
Boydton 4
Hefei 4
Seoul 4
Rome 3
Turku 3
Vienna 3
Frankfurt am Main 2
New York 2
Racale 2
Abidjan 1
Alta Floresta 1
Boardman 1
Cairo 1
Campo Mourão 1
Chapecó 1
Dublin 1
Hong Kong 1
Istanbul 1
Jakarta 1
London 1
Mantena 1
Maracaibo 1
Maricá 1
Marseille 1
Montevideo 1
Moscow 1
Munich 1
Naaldwijk 1
North Bergen 1
Nuremberg 1
Nümbrecht 1
Portsmouth 1
Rio Pardo 1
Rio de Janeiro 1
San Salvador 1
Santa Clara 1
Serra Talhada 1
St Petersburg 1
Taipei 1
Tramandaí 1
Ubatuba 1
Viamão 1
Totale 84
Nome #
Mother and Daughter Carrying of the Same Pathogenic Variant in FGFR2 with Discordant Phenotype 73
Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression 23
Investigating the Effectiveness and Tolerability of Intranasal Esketamine Among Older Adults With Treatment-Resistant Depression (TRD): A Post-hoc Analysis from the REAL-ESK Study Group 19
Targeted allele-specific FGFR2 knockdown via human recombinant ferritin nanoparticles for personalized treatment of Crouzon syndrome 14
Totale 129
Categoria #
all - tutte 739
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 739


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202320 0 0 0 0 10 0 3 1 3 0 3 0
2023/202420 0 4 1 3 2 3 1 0 0 3 1 2
2024/202589 0 0 3 2 1 2 10 2 13 7 32 17
Totale 129